Atorvastatin is in the News

Disclaimer

The information in this article is intended for general educational purposes only and should not replace personalized advice from your GP, cardiologist or other healthcare professional. Never stop taking prescribed medication or make changes to your treatment without first discussing it with a qualified healthcare professional.

Atorvastatin: Understanding the Benefits, Risks and the Latest Research

Statins, including atorvastatin, are among the most commonly prescribed medicines in the UK. Their primary role is to lower LDL (“bad”) cholesterol and reduce the risk of heart attacks and strokes in people at increased cardiovascular risk.

Recently, atorvastatin has returned to the headlines following the publication of one of the largest reviews ever undertaken into statin side effects. The findings have generated considerable discussion among healthcare professionals and patients alike.

This article explains what atorvastatin is, the side effects that are recognised, the latest research findings and what patients should know before making decisions about their treatment.

What is Atorvastatin?

Atorvastatin belongs to a group of medicines known as statins. It works by reducing the amount of cholesterol produced by the liver, helping to lower LDL cholesterol while stabilizing fatty deposits within the arteries.

For many people at high cardiovascular risk, this significantly reduces the likelihood of suffering a heart attack or stroke. It is widely recommended by UK clinical guidelines because of the large body of evidence supporting its effectiveness.

Common Side Effects

Most people who take atorvastatin experience few, if any, problems. However, some people may develop side effects, particularly during the first few months of treatment.

Commonly reported side effects include:

• Muscle aches or stiffness

• Mild muscle weakness

• Headache

• Feeling sick

• Digestive upset

• Joint pain

Many of these symptoms are also common in the general population, making it difficult to determine whether they are caused by the medication itself.

Less Common Side Effects

Less frequently reported side effects include:

• Sleep disturbance

• Dizziness

• Skin rash

• Changes in liver function blood tests

• Increased blood sugar levels in susceptible individuals

Healthcare professionals will consider these alongside a patient’s overall health and cardiovascular risk before deciding whether treatment should continue.

Serious Side Effects

Serious complications are uncommon but can occur.

These include:

• Severe muscle inflammation (myopathy)

• Rhabdomyolysis (extensive muscle damage)

• Significant liver injury

• Severe allergic reactions

Anyone experiencing severe muscle pain, profound weakness, dark urine or jaundice should seek urgent medical advice. These complications are rare but require prompt assessment.

Precautions and Monitoring

Before prescribing atorvastatin, clinicians normally assess:

• Overall cardiovascular risk

• Liver function

• Current medications

• Kidney function where appropriate

• Individual risk factors for diabetes

Routine blood tests may be recommended before treatment begins and repeated if clinically indicated, particularly if symptoms develop or higher doses are used.

Managing Side Effects

If side effects occur, patients should not stop taking atorvastatin without first discussing the problem with their GP or specialist.

Possible management options include:

• Reviewing whether symptoms are likely to be related to the medication.

• Reducing the dose.

• Trying a different statin.

• Considering alternative cholesterol-lowering medicines where appropriate.

• Monitoring symptoms while balancing the individual’s cardiovascular risk.

It is also worth remembering that atorvastatin is only one of several statins available. Medicines such as simvastatin, rosuvastatin, pravastatin and fluvastatin may be suitable alternatives for some patients. Every statin works slightly differently, and some people who experience side effects with one statin may tolerate another very well. If you are experiencing problems, discuss the options with your GP rather than stopping treatment on your own.

For many people, a simple adjustment can resolve symptoms while maintaining the protective benefits of treatment.

Are There Alternatives to Statins?

Yes. While statins remain the first-line treatment for lowering cholesterol, several newer medications are now available for people who cannot tolerate statins or whose LDL (“bad”) cholesterol remains above target despite treatment.

One of the newest options is Inclisiran, which became available on the NHS in 2021 following approval by the National Institute for Health and Care Excellence (NICE).

Unlike statins, which work by reducing the liver’s production of cholesterol, inclisiran uses RNA technology to help the liver remove more LDL cholesterol from the bloodstream by reducing production of a protein called PCSK9.

• What is RNA Technology?

• RNA (ribonucleic acid) is a natural molecule found in every cell of the body. It acts as a messenger, carrying instructions from our DNA to tell cells how to make specific proteins.

• Inclisiran uses a type of RNA technology called small interfering RNA (siRNA). Rather than lowering cholesterol directly, it works by switching off the instructions for making a protein called PCSK9 in the liver. With less PCSK9 being produced, the liver is able to remove more LDL (“bad”) cholesterol from the bloodstream, helping to reduce cholesterol levels for up to six months after each injection.

• Unlike gene therapy, RNA technology does not alter your DNA. It simply reduces the production of one specific protein for a period of time before the body naturally breaks the RNA down.

One of its major advantages is convenience it is given as an injection by a healthcare professional after the initial doses and then only once every six months.

However, inclisiran is not routinely prescribed as a replacement for statins. Under current NHS guidance, it is generally reserved for people who:

• Have established cardiovascular disease or are at very high cardiovascular risk.

• Have LDL cholesterol levels that remain above recommended targets despite taking the maximum tolerated cholesterol-lowering medication.

• Are unable to tolerate statins or other standard cholesterol-lowering treatments.

For many people, atorvastatin continues to provide excellent protection and remains the most appropriate treatment. However, it is reassuring to know that newer therapies are now available for patients who genuinely cannot tolerate statins or whose cholesterol cannot be adequately controlled with conventional treatment.

If you are experiencing troublesome side effects or your cholesterol remains above target, speak to your GP or specialist. They can review your treatment and determine whether an alternative medication such as inclisiran—or another cholesterol-lowering medicine—is appropriate for your individual circumstances.

Key Takeaways from the Latest Research

One of the largest analyses ever conducted, published in The Lancet in 2026, reviewed data from more than 150,000 participants across major randomized clinical trials.

The researchers concluded:

• Most of the side effects listed in statin information leaflets occurred no more frequently in people taking statins than in those taking a placebo.

• There was no convincing evidence that statins caused memory loss, depression, sleep disturbance, erectile dysfunction, weight gain, headaches or many other commonly reported symptoms.

• Genuine side effects do exist, particularly muscle-related problems and abnormal liver blood tests, but these occur in a relatively small proportion of patients.

• For people at increased cardiovascular risk, the reduction in heart attacks and strokes greatly outweighs the relatively small risk of recognized adverse effects.

The findings reinforce an important message: statins remain one of the most effective medicines available for reducing cardiovascular risk, but like all medicines they should be prescribed and monitored on an individual basis.

A Balanced Perspective

Every medicine carries both benefits and risks.

For many people, atorvastatin is an important treatment that significantly reduces the risk of serious cardiovascular disease. Equally, a small number of patients experience genuine side effects that may require a review of their treatment.

The key message is not that statins are either “good” or “bad”. Rather, treatment decisions should always be based on an individual’s medical history, cardiovascular risk and an informed discussion with their healthcare professional.

The rapid development of new cholesterol-lowering treatments, including inclisiran and other non-statin medicines, means that patients now have more options than ever before. The most appropriate treatment will depend on individual circumstances and should always be decided in partnership with a healthcare professional.

At Happy Hearts, we believe the best outcomes come from combining evidence-based medicine with healthy lifestyle choices. Regular physical activity, a balanced diet, maintaining a healthy weight, stopping smoking, managing blood pressure and taking prescribed medication where appropriate all remain essential parts of protecting heart health.

If you have concerns about your cholesterol medication, don’t suffer in silence. Speak to your GP, practice pharmacist or specialist nurse. There may be another statin or a newer cholesterol-lowering treatment that is better suited to your individual needs. The aim is always the same—to reduce your risk of heart attack and stroke while helping you enjoy the best possible quality of life.

References

• Reith C. et al. Assessment of adverse effects attributed to statin therapy in randomised clinical trials. The Lancet, 2026.

• University of Oxford. Statins do not cause the majority of side effects listed in package leaflets. Published 5 February 2026.

• British Heart Foundation. Statin side effects – how many real ones are there? Published March 2026.

• National Institute for Health and Care Excellence (NICE). Inclisiran for treating primary hypercholesterolaemia or mixed dyslipidaemia.

• NHS. Atorvastatin – Uses, side effects and precautions.

• Medicines and Healthcare products Regulatory Agency (MHRA). Statin safety guidance and monitoring recommendations.

• 
  

Happy Hearts Top Tip Never stop taking your statin without speaking to your GP. If you think you’re experiencing side effects, arrange a medication review. There are several statins available, along with newer non-statin treatments, so there may be an option that suits you better while still protecting your heart.